Nonketotic hyperglycinemia: A life-threatening disorder in Saudi newborns

Annals of Saudi Medicine

Volumn 16, Issue 4, 1996, Pages 400-404

  Haider, Nasser ^a   Salih, Mustafa A M ^a,c   Al Rasheed, Soud ^a   Al Mofada, Salih ^a   Krahn, Peter M ^b   Kabiraj, Muslimudin ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN;

APNEA; ARTICLE; CASE REPORT; DELIVERY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HYPERGLYCINEMIA; LETHARGY; MALE; MUSCLE HYPOTONIA; NEWBORN; PRIORITY JOURNAL; SAUDI ARABIA;

EID: 0029812559     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1996.400     Document Type: Article

References (32)

1. Childs B, Nyhan WL, Borden M, Bard L, Cooke RE. Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. I Pediatr 1961;27:522-38.
2. Nyhan WL, Borden M, Childs B. Idiopathic hyperglycinemia: a new disorder of amino acid metabolism. II. The concentration of other amino acids in the plasma and their modification by the administration of leucine. Pediatr 1961;27:539-50.
3. Tada K, Narisawa K, Yoshida T, et al. Hyperglycinemia: a defect in glycine cleavage reaction. Tohoku J Exp Med 1969;98:289-96.
4. Ando T, Nyhan EL, Gerritsen T, Gong L, Heiner DC, Bran PF. Metabolism of glycine in the nonketotic form of hyperglycinemia. Pediatr Res 1968;2:254-63.
5. Baumgartner R, Ando T, Nyhan WL. Nonketotic hyperglycinemia. J Pediatr 1969;75:1022-33.
6. Tada K, Kure S, Takayanagi M, Kume A, Narisawa K. Nonketotic hyperglycinemia: a life-threatening disorder in the neonate. Early Human Dev 1992;29:75-81.
7. Tada K, Kure S. Nonketotic hyperglycinemia: molecular lesion, diagnosis and pathophysiology. J Inherit Metab Dis 1993;16:691- 703.
8. Gitzelmann R, Steinmann B, Otten A, et al. Nonketotic hyperglycinemia treated with strychnine, a glycine receptor antagonist. Helv Paediatr Acta 1977;32:517-25.
9. Yukihiro O, Ochi N, Mizutani N, Hayakawa C, Watanabe K. Nonketotic hyperglycinemia: treatment with NMDA antagonist and consideration of neuropathogenesis. Pediatr Neurol 1991;7:65- 8.
10. Choi DW, Peters S, Viseskul V. Dextrophan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons. J Pharmacol Exp Ther 1987;242:713-20.
11. Kreiger I, Hart ZH. Valine-sensitive nonketotic hyperglycinemia. J Ped 1974;85:43-48.
12. Ohya Y, Ochi N, Mizutani N, Hayakawa C, Watanabe K. Nonketotic hyperglycinemia: treatment with NMDA antagonist and consideration of neuropathogenesis. Pediatr Neurol 1991;7:65- 8.
13. Schmitt B, Steinmann B, Gitzelmann R, Thun-Hohenestein L, Mascher H, Dumermuth G. Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology 1993;43:421-4.
14. Liu H, Worthen HG. Measurement of free amino acid levels in ultrafiltrates of blood plasma by high-performance liquid chromatography with automatic pre-column derivatization. J Chromatogr 1992;579:215-24.
15. Perry TL, Urquhart N, McLean J, et al. Nonketotic hyperglycinemia: glycine accumulation due to absence of glycine cleavage in the brain. N Engl J Med 1975;292:1269-73.
16. Dalla Bernardina B, Aicardi J, Goutierres F, Plouin P. Glycine encephalopathy 1979. Neuropadiatrie 1979;10:209-25.
17. Dalla Bernardina B, Dulac O, Fejerman N, et al. Early myoclonic epileptic encephalopathy. Eur J Pediatr 1983;140:248-52.
18. Zammarchi E, Donati MA, Ciani F, Pasquini E, Pela I, Fiorini P. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia. Neuropediatrics 1994;25:274-6.
19. Nyhan WL, Sakati NA. Diagnostic recognition of genetic disease. Philadelphia: Lea & Febiger, 1986:85-95.
20. Nyhan WL. Nonketotic hyperglycinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th ed. New York: McGraw-Hill, 1989;743-53.
21. Tada K. Nonketotic hyperglycinemia: Clinical and metabolic aspects. Enzyme 1987;38:27-35.
22. Luder AS, Davidson A, Goodman SI, Green CL. Transient nonketotic hyperglycinemia in neonates. J Pediatr 1989;114:1013-5.
23. Schiffmann R, Kayne EM, Willis JK, Africk D, Ampola M. Transient neonatal hyperglycinemia. Ann Neurol 1989;25:201-3.
24. Eyskens FJ, Van Doom JWD, Marien P. Neurologic sequelae in transient nonketotic hyperglycinemia of the neonate. J Pediatr 1992;121:620-1.
25. Trijbels JMF, Monnens LAH, Zee SP van der, Vrenken JA, Sengers RC, Schretlen EDAM. A patient with nonketotic hyperglycinemia: biochemical findings and therapeutic approaches. Ped Res 1974;8:598-605.
26. Nyhan WL. Nonketotic hyperglycinemia. In: Stanbury TB, Fredwickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease, 5th ed. New York: McGraw-Hill, 1983:561-9.
27. Matalon R, Naidu S, Hugher JR, Michals K. NKH: Treatment with diazepam - a competitor for glycine receptors. Pediatrics 1983;71:581-4.
28. Hamosh A, McDonald JW, Valle D, Francomano CA, Nidermeyer E, Johnston MV. Dextromethorphan and high dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 1992;121:131-5.
29. Schmitt B, Steinmann B, Gitzelmann R, Thun-Hohenstein L, Mascher H, Dumermuth G. Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology 1993;43:421-4.
30. Press GA, Barshop BA, Haas RH, Nyhan WL, Glass RF, Hesselink JR. Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. AJNR 1989;10:315-21.
31. Hayasaka K, Tada K, Fueki N, Aikawa J. Prenatal diagnosis of nonketotic hyperglycinemia: enzymatic analysis of the glycine cleavage system in chorionic villi. J Pediatr 1990;116:444-9.
32. Al-Rajeh S, Bademosi O, Ismail H, et al. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology 1993;12:164-78.